NASDAQ
Avalo Therapeutics, Inc. (AVTX) has a revenue compound annual growth rate of -61.19% over 5 years and -3.33% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.